Biotechnology: open SBIR/STTR topics
4 open or upcoming topics mention biotechnology, across 2 agencies. Matched by keywords in the topic title and description.
Animal Biotechnology
SBIR.gov lists this topic without a description. Open the official solicitation for the full scope.
Plant Biotechnology
SBIR.gov lists this topic without a description. Open the official solicitation for the full scope.
Synthetic Biology and Metabolic Engineering
SBIR.gov lists this topic without a description. Open the official solicitation for the full scope.
Universal Platform for Living Adaptive Toxin-removal (UNI-PLAT)
The purpose of this topic area is to catalyze the development of a universal, “plug-and-play” synthetic biology platform that enables next-generation microbial chassis capable of performing a broad array of programmable functions.
Past SBIR/STTR awards in biotechnology
Since 2021, SBIR.gov records 330 SBIR/STTR awards worth $219.9M here. Top agencies: Health and Human Services (244), National Science Foundation (40), Agriculture (16), Defense (14), Energy (11), NASA (3). Most frequent awardees: Epicypher, Inc. (6), TALUS BIOSCIENCE INC (6), CFD RESEARCH CORPORATION (4), ELECTRONIC BIOSCIENCES, INC. (4), GENNEXT TECHNOLOGIES, INC. (4), GLYPHIC BIOTECHNOLOGIES, INC. (4).
- Method for the validation by Western analysis of affinity reagents against post-translationally modified proteins. by ABBRATECH INC. (Phase II, Health and Human Services, 2023, $1,121,971)
- T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy by ABBRATECH INC. (Phase I, Health and Human Services, 2023, $295,460)
- Development of an UNC13A antisense oligonucleotide treatment for ALS and FTD by ACURASTEM INC (Phase II, Health and Human Services, 2023, $1,390,906)
- SBIR Phase I:Targeting the Root Cause of Ewing’s Sarcoma by ALTAY THERAPEUTICS, INC (Phase I, National Science Foundation, 2023, $275,000)
- Recombinant human CC10 protein for treatment and prevention of chronic lung allograft dysfunction by APC BIO INNOVATIONS INC (Phase I, Health and Human Services, 2023, $260,664)
- Scalable single-cell workflow for multiomic analyses of chromatin interactions, accessibility, gene expression and cell surface proteins to unravel mechanisms of cellular diversity by ARIMA GENOMICS, INC. (Phase II, Health and Human Services, 2023, $1,013,363)
- Electronically Addressable DNA Assembly by AVERY DIGITAL DATA, INC. (Phase I, Health and Human Services, 2023, $275,766)
- Multiplexed in vivo assembly of long and complex DNA by BACSTITCH DNA INC. (Phase II, Health and Human Services, 2023, $1,019,428)
- Gelbrane:Combined Gel and Membrane for Robust Western Blotting by BLOTTING INNOVATIONS, LLC (Phase I, Health and Human Services, 2023, $297,664)
- Biomanufacturing 3-Hydroxypropionate through Commercial-Scale Anaerobic Fermentation by BLUESTEM BIOSCIENCES INC (Phase I, Energy, 2023, $199,722)
Source: SBIR.gov public award dataset, matched by keywords. Not an official classification.
Related areas: Biodefense & chemical defense
Get new SBIR/STTR topics every week
New topics, plus everything closing in the next 14 days. Free, one email a week.